ArticlePloS one2019

CRISPR-Cas9 modified bacteriophage for treatment of Staphylococcus aureus induced osteomyelitis and soft tissue infection.

Leah H Cobb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.